Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer

Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter

(2019) Ling-Ling He et al.   Gastroenterology Report

Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival

(2019) Josep M. Llovet et al.   JOURNAL OF HEPATOLOGY

PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

(2019) Xiaoli Liu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection

(2018) Giovanni Marasco et al.   JOURNAL OF HEPATOLOGY

Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

(2018) Kyle J Foreman et al.   LANCET

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

(2017) David J. Pinato et al.   JOURNAL OF HEPATOLOGY

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

(2017) Gonzalo Sapisochin et al.   Nature Reviews Gastroenterology & Hepatology

Validation and ranking of seven staging systems of hepatocellular carcinoma

(2017) Zhan-Hong Chen et al.   Oncology Letters

Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant

(2017) Neil Mehta et al.   JAMA Oncology

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

(2016) A. Martens et al.   CLINICAL CANCER RESEARCH

Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems

(2016) Po-Hong Liu et al.   JOURNAL OF HEPATOLOGY

Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC

(2016) A. Gabrielson et al.   Cancer Immunology Research

Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents

(2015) E. D. Saad et al.   ANNALS OF ONCOLOGY

Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular Carcinoma

(2015) Ju Hyun Shim et al.   ANNALS OF SURGERY

CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful

(2014) H.-J. Kim et al.   Cancer Immunology Research

Artificial neural networks in medical diagnosis

(2013) Filippo Amato et al.   Journal of Applied Biomedicine

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

(2013) K. Han et al.   NEURO-ONCOLOGY

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

(2011) Shuichiro Shiina et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

CD4 T Cells Promote CD8 T Cell Immunity at the Priming and Effector Site during Viral Encephalitis

(2011) T. W. Phares et al.   JOURNAL OF VIROLOGY

Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

(2010) Fidel-David Huitzil-Melendez et al.   JOURNAL OF CLINICAL ONCOLOGY

Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

(2010) Alejandro Forner et al.   SEMINARS IN LIVER DISEASE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE